Fig. 5.

Effects of ATO on xenograft tumor model a. Gross tumor extracted from nude mouse after 6 weeks of intraperitoneal administration of ATO with or without pervanadate. b. Difference in mean tumor volume among three groups. Data are presented as mean ± standard deviation. ^*P < 0.05, compared with control (n = 5). c. Changes of mean body weight. Data are presented as mean ± standard deviation. d. Immunohistochemistry of xenograft tumor. The SHP-1 protein expressions were stained dark brown